Elutia Inc (ELUT) Announces Regulatory Update
Elutia Inc (ELUT) provided an update on regulatory developments for its product portfolio.
Regulatory Update Details:
• Applications: NDA (New Drug Application)
• Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency)
• Status: Rejected
Clinical Development:
📋 Elutia Inc (ELUT) - Regulatory Update
Filing Date: 2026-01-12
Accepted: 2026-01-12 08:51:45
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (Elutia Inc):
💼 Business Developments:
Structured Data: